Lifeboat Foundation

Including decaffeinated and instant ones.

A new study conducted by Australian scientists suggests that consuming two to three cups of decaffeinated, ground, and instant coffee can lower the risk of developing cardiovascular disease and dying early.

“In this large, observational study, ground, instant, and decaffeinated coffee were associated with equivalent reductions in the incidence of cardiovascular disease and death from cardiovascular disease or any cause,” says study author Professor Peter Kistler of the Baker Heart and Diabetes Research Institute in a media release.

Continue reading “Drinking 2 to 3 cups of coffee per day could have a surprising effect on longevity” »

Are NFTs seeing a revival in different “avatars”, though?

The rage among celebrities last year, non-fungible tokens (NFTs), have been hit badly by the crypto winter and have seen sales dip by 98 percent in the eight months since January, Coin Telegraph.

How bad are trading volumes for NFTs?

Continue reading “NFT sales plummet 98% in eight months of this year” »

We wonder what Tesla is going to reveal.

Once again, it is that time of the year. The annual Tesla AI Day, a demonstration of the most cutting-edge technologies from all of the company’s operating divisions is tomorrow. While Tesla vehicles receive the majority of press attention, the company has a wide range of other applications and products that it is constantly developing and improving.

Continue reading “AI Day 2022: Tesla may unveil a major milestone for its Optimus robot” »

😗

Illumina just announced a machine that can crack genomes twice as fast as its current version—and drive the cost down to $200 a pop.

In adult mice with loss of CHD8 gene function, FDA-approved drug partially restores disrupted brain cell production

CINCINNATI, Sept. 23, 2022 /PRNewswire/ — Research led by a scientist at Cincinnati Children’s who primarily studies brain tumors may open doors for improved treatment of autism.

Autism spectrum disorder (ASD) affects about one in 40 children between ages 3 and 17, according to the National Survey of Children’s Health. Those affected often experience difficulty socializing, impaired language development, repetitive behaviors, and other symptoms. Of those tested for various genes linked to the condition, nearly everyone with disruptive mutations of the gene CHD8 has autism.

The 100 MW Dalian Flow Battery Energy Storage Peak-shaving Power Station, with the largest power and capacity in the world so far, was connected to the grid in Dalian, China, on September 29, and it will be put into operation in mid-October.

This energy storage project is supported technically by Prof. Li Xianfeng’s group from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences. And the system was built and integrated by Rongke Power Co. Ltd.

The Dalian Flow Battery Energy Storage Peak-shaving Power Station was approved by the Chinese National Energy Administration in April 2016. As the first national, large-scale chemical energy storage demonstration project approved, it will eventually produce 200 megawatts (MW)/800 megawatt-hours (MWh) of electricity.

NASA and SpaceX signed an unfunded Space Act Agreement Thursday, Sept. 22, to study the feasibility of a SpaceX and Polaris Program idea to boost the agency’s Hubble Space Telescope into a higher orbit with the Dragon spacecraft, at no cost to the government.

The joint observation is a first for Hubble and Webb, and it proves the space telescopes are allies, not rivals.

Personalized Bio-Engineered Human Hearts For All — Dr. Doris A. Taylor, Ph.D., CEO, Organamet Bio Inc.

Dr. Doris A. Taylor, Ph.D. is Chief Executive Officer of Organamet Bio Inc. (https://organametbio.com/) an early phase start-up committed to saving lives and reducing the cost of healthcare for those with heart disease. Organamet has a goal is to make personalized bio-engineered human hearts, available to all who need them, within 5 years, increasing availability and access to hearts, decreasing or eliminating need for immunosuppression, reducing total lifetime transplant costs, and improving quality of life.

Continue reading “Dr. Doris A. Taylor, Ph.D. — CEO, Organamet Bio Inc. — Personalized Bio-Engineered Human Hearts” »